The Leprosy Research Initiative envisions a world free from leprosy
The LRI is a combined venture of ILEP members and closely associated partners. The LRI was launched in 2013 to establish a joint fund to support leprosy research and mechanisms to access external funding.
We fund research
The joint fund is used for research that is exclusively or strongly related to leprosy. Additional resources are actively sought for research in the field of general disabilities and for research aimed at different diseases (e.g. other NTDs, TB and diabetes) in combination with leprosy. Since 2014, the Leprosy Research Initiative has supported more than 45 different projects spread over six continents.
Open call for proposals (budget round 2021)
The Leprosy Research Initiative (LRI) is pleased to announce a call for proposals for funding commencing in 2021. LRI funds research with a focus on leprosy – including research applications combining leprosy with other neglected tropical diseases (NTDs) or other diseases that share cross-cutting issues with leprosy. Please click here to find out the criteria, how we work and how to apply for funding.
Call for external reviewers
We are a partnership
The Leprosy Research Initiative is led by an Executives Group of primary funders including: NLR, American Leprosy Missions (ALM), German Leprosy and Tuberculosis Relief Association (GLRA), effect:hope (The Leprosy Mission Canada) and The Leprosy Mission International (TLMI). Our associate partners are: The Mission to End Leprosy (formerly known as TLM Ireland), Plan:G (formerly the Austrian leprosy Relief Association) and Damian Foundation. We collaborate with the Global Partnership for Zero Leprosy.